To view or add a comment, sign in Open Access: Results from the TRIUMPH study demonstrate reduction in mean monthly #headache days & improved functioning after 3 months of starting #galcanezumab compared to traditional oral #migraine preventive medications Article link: richard lipton, Miguel J
Gorilla Mode AR Suggested Use Coming soon
**Who should still consider it:** Patients who prefer daily rather than weekly dosing (a small minority), those who respond poorly to newer agents, or situations where cost and insurance coverage strongly favor Saxenda
And that's often what matters most when appetite shifts are part of everyday life
DPP4 inhibitor, which could inhibit the degradation of endogenous GLP-1, can stimulate the activation of AMPK and fatty degeneration in adipocyte (Cheng et al., 2019)
Other research has highlighted its protective effects on the gastrointestinal (GI) tract, including accelerated healing of ulcers and mitigated damage from toxins